Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001534463 | SCV001751395 | likely benign | not provided | 2018-09-11 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV004017651 | SCV004848594 | benign | not specified | 2021-11-09 | criteria provided, single submitter | clinical testing | The c.1146+129C>T variant in GATA4 is classified as benign because it has been identified in 3.38% (294/8710) of African/African-American chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP codes applied: BA1 |
Central Research Laboratory, |
RCV000497522 | SCV000590813 | pathogenic | Congenital heart disease | 2017-01-07 | no assertion criteria provided | clinical testing | |
Reproductive Health Research and Development, |
RCV000497522 | SCV001142383 | benign | Congenital heart disease | 2020-01-06 | no assertion criteria provided | curation | NG_008177.2(NM_002052.4):c.1146+129C>T in the GATA4 gene has an allele frequency of 0.034 in African subpopulation in the gnomAD database. 8 homozygous occurrences are observed in the gnomAD database. Benign computational verdict because benign prediction from DANN. Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, BP4. |